- Home
- INDP vs LUXH Comparison
INDP vs LUXH Comparison
Compare INDP & LUXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INDP
- LUXH
- Stock Information
- Founded
- INDP 2000
- LUXH 2017
- Country
- INDP United States
- LUXH United States
- Employees
- INDP N/A
- LUXH N/A
- Industry
- INDP Biotechnology: Pharmaceutical Preparations
- LUXH Real Estate
- Sector
- INDP Health Care
- LUXH Finance
- Exchange
- INDP Nasdaq
- LUXH Nasdaq
- Market Cap
- INDP 15.4M
- LUXH 12.7M
- IPO Year
- INDP N/A
- LUXH N/A
- Fundamental
- Price
- INDP $1.16
- LUXH $0.08
- Analyst Decision
- INDP Strong Buy
- LUXH Buy
- Analyst Count
- INDP 1
- LUXH 3
- Target Price
- INDP $12.00
- LUXH $10.00
- AVG Volume (30 Days)
- INDP 21.1K
- LUXH 9.3M
- Earning Date
- INDP 11-04-2024
- LUXH 11-06-2024
- Dividend Yield
- INDP N/A
- LUXH N/A
- EPS Growth
- INDP N/A
- LUXH N/A
- EPS
- INDP N/A
- LUXH N/A
- Revenue
- INDP N/A
- LUXH $90,865,323.00
- Revenue This Year
- INDP N/A
- LUXH N/A
- Revenue Next Year
- INDP N/A
- LUXH $15.51
- P/E Ratio
- INDP N/A
- LUXH N/A
- Revenue Growth
- INDP N/A
- LUXH 14.73
- 52 Week Low
- INDP $1.03
- LUXH $0.07
- 52 Week High
- INDP $3.25
- LUXH $6.88
- Technical
- Relative Strength Index (RSI)
- INDP 36.05
- LUXH 46.07
- Support Level
- INDP $1.11
- LUXH $0.07
- Resistance Level
- INDP $1.27
- LUXH $0.08
- Average True Range (ATR)
- INDP 0.13
- LUXH 0.01
- MACD
- INDP -0.00
- LUXH 0.00
- Stochastic Oscillator
- INDP 22.03
- LUXH 21.22
About INDP Indaptus Therapeutics Inc.
Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's pre-clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.
About LUXH LuxUrban Hotels Inc.
LuxUrban Hotels Inc utilizes a long term lease, asset-light business model to acquire and manage a growing portfolio of short-term rental properties in metropolitan cities. It identifies, acquires, manages, and markets hotel rooms to business and vacation travelers under the consumer brand, LuxUrban. It manages a portfolio of hotel rooms in New York, Washington D.C., Miami Beach, New Orleans and Los Angeles.